investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Eiger Biopharmaceuticals Inc
(28249U105)

Funds Reporting Holdings of Eiger Biopharmaceuticals Inc according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
683 Capital Management LLC 1,835,529 $19,457k Jun 30, 2019 Aug 14, 2019
VIVO Capital LLC 1,791,257 $18,987k Jun 30, 2019 Aug 13, 2019
Broadfin Capital LLC 1,656,137 $17,555k Jun 30, 2019 Aug 14, 2019
Ecor1 Capital LLC 1,136,043 $12,042k Jun 30, 2019 Aug 14, 2019
Farallon Capital Management LLC 1,000,000 $10,600k Jun 30, 2019 Aug 14, 2019
Mangrove Partners 847,284 $8,981k Jun 30, 2019 Aug 14, 2019
Telemetry Investments LLC 376,035 $3,986k Jun 30, 2019 Aug 14, 2019
Renaissance Technologies LLC 298,613 $3,165k Jun 30, 2019 Aug 12, 2019
Driehaus Capital Management LLC 60,000 $636k Jun 30, 2019 Aug 14, 2019
Tocqueville Asset Management LP 34,250 $363k Jun 30, 2019 Jul 31, 2019
Sanders Morris Harris LLC 31,500 $344k Jun 30, 2019 Jul 10, 2019
Spark Investment Management LLC 14,886 $157k Jun 30, 2019 Aug 12, 2019
Acadian Asset Management LLC 11,602 $123k Jun 30, 2019 Aug 8, 2019
Prelude Capital Management LLC 144 $2k Jun 30, 2019 Aug 14, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.